Market Outlook

By 2035, the U.S. IVD Sample Preparation Systems Market is estimated to reach approximately USD 11.84 billion, expanding at an aggressive CAGR of 9.18% during the forecast period 2026–2035. The market is estimated at USD 4.92 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. IVD sample preparation systems industry occupies a critical position between specimen collection and analytical testing. Every molecular, genomic, infectious disease, oncology, immunodiagnostic, cytology, hematology, and specialized clinical laboratory workflow depends on the reliability of pre-analytical processing. Sample preparation systems perform functions such as accessioning, aliquoting, centrifugation, extraction, purification, lysis, nucleic-acid isolation, concentration, normalization, reagent dispensing, liquid handling, library preparation, and transfer of specimens into downstream diagnostic platforms.

The addressable U.S. laboratory infrastructure is exceptionally large. CMS data covering the first quarter of 2026 identify approximately 302,300 active or certified clinical laboratory providers, illustrating the scale and fragmentation of the national testing ecosystem. At the same time, the laboratory workforce remains operationally constrained. Approximately 351,200 clinical laboratory technologists and technicians were employed in 2024, while around 22,600 occupational openings are projected annually over the 2024–2034 period. This mismatch between laboratory demand and available skilled labor is increasing the economic value of automated sample preparation.

Historical market value increased from an estimated USD 3.31 billion in 2021 to USD 4.42 billion in 2024, supported by the normalization of routine diagnostic volumes after the pandemic, sustained molecular testing infrastructure, higher oncology testing intensity, growth of next-generation sequencing, broader adoption of automated nucleic-acid extraction, and laboratory investment in higher-throughput liquid handling. The market reached approximately USD 4.92 billion in 2025 as automation increasingly moved from large reference laboratories into hospital molecular laboratories, pathology departments, regional health systems, specialized oncology laboratories, transplant laboratories, and decentralized genomic testing facilities.

The market is entering a new investment cycle in which laboratories are evaluating sample preparation systems less as isolated bench instruments and more as productivity infrastructure. Purchasing decisions increasingly reflect hands-on time per specimen, throughput per technologist, contamination risk, extraction consistency, reagent utilization, laboratory information system connectivity, footprint, staffing flexibility, validation burden, instrument uptime, and compatibility with multiple downstream assays.

From 2026 through 2035, market expansion will increasingly be driven by automated molecular workflows, oncology and liquid biopsy testing, high-throughput nucleic-acid purification, sample-to-answer diagnostics, automated NGS preparation, integrated liquid handling, laboratory consolidation, and pressure to generate more diagnostic output without proportional expansion of laboratory staffing.

 

Introduction

According to the U.S. IVD Sample Preparation Systems Market Report, sample preparation represents one of the most operationally important stages of diagnostic testing because analytical accuracy cannot compensate for a poorly processed specimen. Insufficient nucleic-acid yield, contamination, incorrect aliquoting, specimen degradation, inconsistent purification, pipetting error, cross-contamination, or improper sample normalization can compromise the reliability of downstream diagnostic results.

The market therefore extends well beyond traditional benchtop extraction instruments. It includes automated nucleic-acid extraction systems, liquid handling workstations, robotic sample processors, pre-analytical automation, centrifugation and separation platforms, purification technologies, magnetic-bead processing systems, NGS library preparation platforms, integrated sample-to-answer systems, and software-controlled workflow automation.

Demand is supported by the enormous testing burden generated by chronic and infectious disease. Approximately 38 million U.S. adults have diabetes, creating recurring diagnostic requirements across chemistry, renal, metabolic, and biomarker testing. Cancer is another major demand engine: approximately 2.04 million new cancer diagnoses were projected in the United States during 2025, increasing requirements for tissue processing, molecular profiling, companion diagnostics, liquid biopsy, hereditary cancer testing, and sequencing workflows.

Infectious disease testing creates an additional high-volume use case. During June 2024 through June 2025, 297 laboratories participating in a CDC surveillance network reported approximately 3.96 million SARS-CoV-2 PCR test results. During the 2023–2024 influenza season, participating clinical laboratories reported approximately 3.91 million respiratory specimens tested for influenza viruses. These figures represent only surveillance-reporting laboratories rather than total U.S. diagnostic volume, but they demonstrate the continuing scale of molecular specimen processing requirements.

The economics of U.S. healthcare also support laboratory automation investment. National healthcare expenditures reached approximately USD 5.3 trillion in 2024, while hospital spending reached approximately USD 1.63 trillion. Laboratories operating inside large health systems must support increasing test menus while managing labor costs, turnaround-time commitments, quality metrics, supply-chain requirements, and reimbursement pressure.

For manufacturers, the strategic opportunity is increasingly concentrated around workflow consolidation. Laboratories prefer platforms capable of supporting multiple sample types, multiple extraction chemistries, variable batch sizes, random access, bidirectional LIS connectivity, standardized protocols, automated quality controls, and compatibility with different downstream analytical systems. Open or semi-open automation architectures can be especially attractive to laboratories seeking flexibility across multiple assay vendors.

 

Key Market Drivers: What’s Fueling the U.S. IVD Sample Preparation Systems Market Boom?

The strongest structural driver is the continued expansion of molecular diagnostics. PCR, digital PCR, NGS, multiplex infectious disease testing, transplant diagnostics, inherited disease testing, reproductive genetics, oncology profiling, pharmacogenomics, and companion diagnostics all require reliable upstream handling of DNA, RNA, plasma, serum, blood, tissue, swabs, and other clinical specimens.

As molecular menus become larger, manual extraction becomes increasingly difficult to justify. Automated systems improve batch consistency and reduce the amount of skilled technologist time consumed by repetitive pipetting, washing, magnetic-bead separation, transfer, and normalization activities. The economic advantage becomes particularly significant in laboratories operating multiple shifts or processing hundreds to thousands of specimens per day.

Laboratory staffing pressure is another fundamental growth driver. The U.S. employed approximately 351,200 clinical laboratory technologists and technicians in 2024, but laboratories continue to face replacement hiring and specialist shortages. Automated preparation allows skilled personnel to spend less time on repetitive processing and more time on quality review, exception handling, assay validation, troubleshooting, and interpretation.

Oncology diagnostics represent one of the highest-value growth opportunities. More than two million new U.S. cancer diagnoses annually create substantial demand for biopsy processing, formalin-fixed paraffin-embedded tissue workflows, circulating tumor DNA testing, molecular profiling, tumor-normal sequencing, hereditary cancer panels, minimal residual disease testing, and biomarker analysis. The complexity of oncology specimens favors systems capable of extracting high-quality material from low-input, degraded, or heterogeneous samples.

Liquid biopsy is particularly important because it increases the importance of pre-analytical precision. Circulating cell-free DNA and circulating tumor DNA may exist at low concentrations, meaning that differences in collection, centrifugation, extraction, purification, and recovery can materially influence analytical performance. Technologies that increase recovery while reducing manual transfer steps can therefore command premium value in oncology and precision-medicine laboratories.

NGS adoption represents another major market catalyst. Sequencing economics have improved dramatically, but upstream library preparation remains labor-intensive. Fragmentation, indexing, amplification, cleanup, normalization, pooling, and plate handling can become major workflow bottlenecks. Consequently, diagnostic and translational laboratories increasingly evaluate robotic liquid handling and validated automated library preparation.

Hospital and reference laboratory consolidation further supports automation. Large integrated delivery networks frequently seek to centralize complex molecular testing across regional laboratories. Centralization increases specimen volume and makes capital investment in higher-throughput extraction and robotic preparation financially attractive. A single standardized platform may replace multiple labor-intensive workflows while reducing training variation across sites.

Infectious disease preparedness remains another durable driver. The pandemic accelerated U.S. investment in molecular extraction and high-throughput processing infrastructure. Although COVID-19 testing has normalized, the installed automation base is increasingly being redirected toward influenza, RSV, gastrointestinal infections, sexually transmitted infections, transplant viruses, antimicrobial resistance, emerging pathogens, and laboratory-developed molecular assays.

Reimbursement economics will also shape purchasing behavior. Medicare primarily pays clinical diagnostic laboratory tests under the Clinical Laboratory Fee Schedule. As of 2026, the statutory phase-in of certain payment reductions remains delayed for that year, while reductions beginning in 2027 through 2029 may be capped at 15% annually for affected tests. Laboratories therefore remain under pressure to lower cost per reportable result even when test demand rises. Automation that reduces labor intensity, repeat testing, reagent waste, and error rates can strengthen the business case for sample preparation investment.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation is increasingly centered on removing manual intervention between specimen receipt and analytical testing. The strongest platforms are evolving from standalone extractors toward connected workflow systems combining sample identification, liquid handling, extraction, purification, amplification setup, assay preparation, and digital documentation.

High-throughput magnetic-bead extraction remains one of the most commercially important innovation areas. Magnetic-particle chemistry allows laboratories to automate binding, washing, and elution without traditional column-based centrifugation. Platforms capable of processing up to 96 samples per run are increasingly common in molecular and genomic laboratories. Thermo Fisher’s KingFisher Apex, for example, is designed for automated purification of DNA, RNA, proteins, and cells in configurations supporting up to 96 samples per run, illustrating the throughput direction of modern laboratory preparation platforms.

Robotic liquid handling is becoming more sophisticated as laboratories demand variable-volume pipetting, plate handling, barcode tracking, integrated thermal cycling, centrifugation, shaking, incubation, and third-party instrument integration. Modern robotic platforms are therefore transitioning from programmable pipetting stations into orchestrators of complete diagnostic workflows.

NGS automation is a particularly active development area. Beckman Coulter Life Sciences introduced its Biomek Echo One platform with capabilities spanning extraction, fragmentation, ligation, normalization, pooling, centrifugation, shaking, and thermal incubation within automated genomic workflows. These integrated approaches are valuable because library preparation remains one of the most technically demanding and operator-sensitive stages of sequencing.

Manufacturers are also emphasizing smaller-footprint automation. Historically, high-throughput robotic systems primarily served large reference or academic laboratories. Newer instruments increasingly target laboratories requiring automation without industrial-scale floor space. Compact extraction instruments can enable community hospitals, regional oncology laboratories, transplant centers, and decentralized molecular facilities to obtain workflow consistency without building large automation lines.

Random-access and continuous-access processing are becoming strategically important. Batch-only systems can create delays when urgent specimens arrive between scheduled runs. Laboratories increasingly favor platforms that can prioritize specimens, accommodate different assays or sample types, and reduce the need to wait for full batches.

Connectivity is becoming another competitive differentiator. Bidirectional LIS communication, automated barcode reading, digital chain-of-custody documentation, remote instrument monitoring, predictive maintenance, workflow analytics, and standardized protocol libraries reduce administrative burden while improving traceability.

Sample-to-answer systems represent a parallel innovation path. Highly integrated platforms combine extraction, amplification, detection, and result generation. Hologic’s Panther architecture demonstrates the commercial importance of scalable automation, with configurations capable of processing very high daily test volumes while minimizing manual intervention. Expansion of testing menus increases utilization of the installed preparation infrastructure and strengthens recurring revenue economics.

The next competitive frontier will be intelligent workflow orchestration. Laboratories will increasingly expect automation software to predict run capacity, prioritize STAT specimens, optimize plate layouts, track consumable inventory, identify process deviations, and document compliance. The value of future sample preparation platforms will therefore be determined by both mechanical automation and the information layer controlling laboratory operations.

 

Segmentation Insights

The U.S. IVD Sample Preparation Systems Market is segmented on the basis of product type, sample type, application, automation level, and end user.

 

By Product Type

Automated Nucleic Acid Extraction and Purification Systems

Automated nucleic-acid extraction and purification systems represent one of the largest and fastest-growing product categories. These instruments isolate DNA and RNA from blood, plasma, serum, tissue, swabs, saliva, urine, stool, and other clinical specimens for downstream PCR, digital PCR, sequencing, genotyping, and molecular diagnostic workflows.

Growth is being driven by infectious disease testing, oncology, liquid biopsy, transplantation, inherited disease testing, and reproductive genetics. Magnetic-bead-based extraction has gained substantial workflow importance because it supports automation across small and large batch sizes while reducing manual centrifugation.

Automated Liquid Handling Workstations

Liquid handling platforms are gaining strategic importance as laboratories automate multi-step assay preparation. These systems perform pipetting, reagent dispensing, dilution, normalization, plate setup, sample transfer, pooling, and library preparation.

Higher-end workstations increasingly integrate readers, incubators, centrifuges, thermal modules, shakers, and laboratory information systems. Demand is particularly strong in NGS, specialty molecular testing, large hospital laboratories, reference laboratories, and precision medicine programs.

Pre-Analytical Sample Processing Systems

Pre-analytical systems include specimen sorting, decapping, aliquoting, centrifugation, labeling, tube handling, transport, and automated routing technologies. These products are critical in high-volume laboratories because a significant portion of laboratory operational errors can originate before analytical measurement.

Integrated pre-analytics has become especially important for core laboratories seeking faster turnaround and less manual specimen movement.

NGS and Genomic Sample Preparation Systems

NGS preparation systems automate nucleic-acid quantification, fragmentation, cleanup, target enrichment, indexing, library amplification, normalization, and pooling. This category is expected to outperform the broader market as sequencing expands further into oncology, inherited disease, reproductive medicine, infectious disease, and pharmacogenomics.

The strongest demand is expected from laboratories attempting to move sequencing from specialist research workflows into repeatable clinical production environments.

Integrated Sample-to-Answer Systems

Integrated systems combine sample preparation directly with amplification, detection, or other downstream analytical functions. These platforms are attractive because they reduce operator intervention and shorten the distance between specimen loading and actionable results.

Growth will be especially strong where laboratories require high throughput, standardized workflows, predictable turnaround time, and broad assay consolidation.

 

By Sample Type

Blood, Plasma, and Serum

Blood-derived specimens account for a major share of sample preparation demand. Applications span infectious disease, oncology, prenatal testing, transplantation, hematology, immunology, chemistry, pharmacogenomics, and cardiovascular diagnostics.

Plasma processing is gaining additional importance from liquid biopsy and circulating cell-free DNA applications. High-quality separation and nucleic-acid recovery are critical because low-concentration biomarkers can be affected by pre-analytical variation.

Tissue and FFPE Samples

Tissue preparation is heavily associated with oncology, pathology, molecular diagnostics, and companion testing. Formalin-fixed paraffin-embedded specimens are challenging because nucleic acids can be fragmented or chemically modified.

Systems that achieve consistent extraction from difficult tissue samples can create measurable downstream value by reducing sequencing failure, repeat extraction, and insufficient-sample rates.

Swabs and Respiratory Specimens

Respiratory, nasopharyngeal, nasal, genital, and other swab specimens remain important for infectious disease diagnostics. Automated preparation supports seasonal respiratory testing as well as sexually transmitted infection and other molecular testing.

The substantial molecular respiratory test volumes observed through U.S. surveillance systems demonstrate the continued requirement for scalable sample handling even after pandemic-era testing declined.

Urine, Saliva, and Other Body Fluids

Urine and saliva are increasingly important in urology, infectious disease, endocrinology, drug testing, hormone testing, and selected molecular applications. Cerebrospinal fluid, synovial fluid, stool, bone marrow, and other specialized specimens require additional processing capabilities because of their distinct matrices.

The commercial advantage increasingly belongs to systems capable of supporting diverse specimen types without extensive manual reconfiguration.

 

By Application

Molecular and Infectious Disease Diagnostics

Molecular diagnostics represent the largest application area for automated sample preparation. Nucleic-acid extraction is fundamental to PCR and other amplification-based testing for respiratory pathogens, sexually transmitted infections, gastrointestinal infections, hepatitis, HIV, transplant viruses, and emerging pathogens.

Laboratories increasingly favor preparation platforms supporting broad molecular menus because instrument utilization improves when multiple applications can share extraction infrastructure.

Oncology and Precision Medicine

Oncology is expected to be one of the fastest-growing applications through 2035. More than two million new U.S. cancer diagnoses annually provide a substantial clinical base for genomic profiling, companion diagnostics, hereditary testing, liquid biopsy, measurable residual disease, and molecular pathology.

Automation is particularly valuable in oncology because workflows frequently involve low-input specimens, expensive downstream sequencing, and clinically significant turnaround requirements.

Genomics and Genetic Testing

Genomics applications include hereditary disease panels, whole-exome sequencing, whole-genome sequencing, pharmacogenomics, reproductive genetics, rare disease testing, and large targeted panels.

As clinical sequencing volume expands, laboratories need greater consistency in library preparation. Automated liquid handling reduces operator-to-operator variation and enables more predictable batching.

Clinical Chemistry, Immunodiagnostics, and Hematology

High-volume routine laboratories use automated specimen sorting, centrifugation, aliquoting, dilution, and transfer before analysis. Although these workflows may require less nucleic-acid extraction than molecular laboratories, the enormous routine test volume creates substantial demand for pre-analytical automation.

The business case centers on reducing manual tube handling and improving analyzer utilization.

Pathology and Specialized Diagnostics

Pathology, cytology, transplant diagnostics, reproductive health, microbiology, toxicology, and specialized reference testing create additional demand for customizable preparation systems.

These markets tend to favor flexible automation because specimen characteristics and assay workflows may vary substantially.

 

By Automation Level

Fully Automated Systems

Fully automated platforms represent the fastest-growing segment because they reduce hands-on time, standardize procedures, improve traceability, and allow laboratories to increase output without proportionate staffing increases.

Demand is strongest among reference laboratories, integrated delivery networks, molecular diagnostic laboratories, and high-volume hospital facilities.

Semi-Automated Systems

Semi-automated instruments remain commercially important where laboratories require standardized extraction or purification but do not need fully integrated robotics. They often provide an attractive balance between capital cost, throughput, flexibility, and operational control.

Community hospitals and medium-volume specialty laboratories represent important customers.

Manual and Modular Preparation Systems

Manual and modular systems retain relevance for low-volume testing, specialized assays, validation work, and laboratories requiring maximum protocol flexibility.

However, their share of market value is expected to gradually decline as labor economics and quality requirements favor greater automation.

 

By End User

Hospitals and Health Systems

Hospitals and integrated health systems represent the largest end-user segment. Their laboratories process routine chemistry, hematology, microbiology, molecular, pathology, blood bank, oncology, and emergency diagnostic specimens.

Large health systems increasingly standardize laboratory automation across multiple facilities and evaluate investments using total cost per result, staffing productivity, turnaround time, instrument uptime, service coverage, and supply-chain security.

Independent and Commercial Reference Laboratories

Reference laboratories are among the heaviest users of high-throughput sample preparation because they process large specimen volumes across broad test menus.

Their operating model favors scalable automation, high instrument utilization, standardized protocols, large reagent contracts, and strong laboratory information system integration.

Molecular and Genomic Diagnostic Laboratories

Specialized molecular and genomic laboratories are a high-growth customer group. These facilities rely heavily on extraction, purification, liquid handling, normalization, and sequencing preparation.

Their purchasing decisions frequently prioritize reproducibility, low-input performance, assay flexibility, automation script availability, and compatibility with downstream sequencing systems.

Academic Medical Centers and Research-Integrated Clinical Laboratories

Academic medical centers frequently act as early adopters of new sample preparation technologies. These institutions conduct complex testing, validation studies, translational genomics, and laboratory-developed workflows.

They are influential because successful implementation can support broader adoption through clinical publications, specialist training, and reference laboratory relationships.

Specialty Laboratories and Other Diagnostic Facilities

Oncology laboratories, fertility laboratories, transplant laboratories, pathology facilities, public health laboratories, physician-office laboratories, and other specialty settings create a diverse additional market.

The most attractive systems in this segment typically combine compact footprints with flexible protocols and moderate throughput.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. IVD Sample Preparation Systems Market is geographically segmented into the South, Northeast, West, and Midwest. Regional demand differs according to population scale, clinical laboratory density, hospital system concentration, oncology infrastructure, genomics activity, academic research capacity, molecular testing adoption, workforce availability, and the concentration of major commercial reference laboratories.

The South represents the largest regional market in 2025, while the West is projected to record the fastest growth through 2035. The Northeast remains the most concentrated premium market for academic diagnostics, molecular pathology, and clinical genomics, while the Midwest provides a large and stable hospital and reference-laboratory installed base.

South

The South is estimated to account for approximately USD 1.62 billion in 2025, representing roughly one-third of national market value. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Tennessee, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, Kentucky, West Virginia, and other Southern markets.

Regional leadership is supported by rapid population growth, large metropolitan healthcare systems, substantial chronic disease burden, strong oncology volumes, expansion of molecular laboratories, and continued investment in centralized health-system testing.

Texas represents the largest Southern opportunity. Houston, Dallas-Fort Worth, Austin, and San Antonio support extensive hospital networks, cancer centers, academic institutions, transplant programs, and commercial laboratory operations. Sample preparation demand is distributed across high-throughput core laboratories, molecular oncology, infectious disease, genomics, and specialized reference testing.

Texas is particularly attractive for automation vendors because large health systems can deploy standardized platforms across multiple hospitals. Enterprise procurement can produce substantial instrument placements when vendors demonstrate service reliability, assay flexibility, competitive consumable economics, and LIS integration.

Florida represents another major state market. Its large and aging population supports high diagnostic intensity across oncology, chronic disease, infectious disease, pathology, and hospital laboratory testing. Health-system consolidation and growth in major metropolitan areas including Miami, Tampa, Orlando, and Jacksonville increase opportunities for scalable sample preparation.

Florida’s aging demographics also create strong demand for cancer diagnosis and monitoring. As oncology laboratories expand molecular profiling and liquid biopsy services, automated plasma processing, nucleic-acid extraction, and sequencing preparation should gain importance.

North Carolina has an outsized strategic role because of the Research Triangle, major academic medical centers, biotechnology activity, pharmaceutical research, and sophisticated hospital systems. The state offers strong demand for genomic preparation, NGS automation, molecular diagnostics, and translational laboratory workflows.

Georgia benefits from Atlanta’s large healthcare market, public health infrastructure, academic institutions, and regional referral networks. Molecular testing, hospital automation, infectious disease diagnostics, and oncology are major demand areas.

Virginia and Maryland benefit from large health systems, academic medicine, federal research activity, biotechnology clusters, and proximity to national public health and research institutions. Maryland is particularly relevant for genomics, oncology, and high-complexity laboratory testing.

Tennessee has a significant hospital and reference-laboratory presence, while Kentucky, Alabama, Louisiana, Mississippi, Arkansas, Oklahoma, South Carolina, and West Virginia generate growing demand for workflow automation as laboratories seek to manage staffing constraints and consolidate complex testing into regional hubs.

The South is expected to remain the largest regional market through 2035, potentially exceeding USD 3.7 billion. Growth will come from molecular testing, oncology diagnostics, integrated health-system laboratory networks, sequencing adoption, and migration from manual to automated sample preparation.

West

The West is estimated at approximately USD 1.14 billion in 2025 and is projected to be the fastest-growing region during the forecast period. The region includes California, Washington, Arizona, Colorado, Oregon, Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is by far the largest Western state market. Its combination of major academic medical centers, integrated health systems, genomics companies, biotechnology firms, precision medicine programs, cancer centers, and venture-backed diagnostic developers makes the state one of the country’s most sophisticated sample preparation markets.

California laboratories are often early adopters of robotic liquid handling, sequencing automation, liquid biopsy preparation, digital workflow management, and high-throughput extraction. Competition is consequently less focused on basic automation capability and more focused on flexibility, validated workflows, sample recovery, data integration, and cost per library or result.

The San Francisco Bay Area, San Diego, Los Angeles, Orange County, and Sacramento each provide distinct demand clusters. Northern California has strong genomic and biotechnology activity, while Southern California combines large healthcare delivery markets with diagnostics and life-science innovation.

Washington is important because of Seattle’s academic medicine, oncology, genomic research, and technology ecosystem. Laboratories in the state are attractive targets for automated NGS and high-complexity molecular preparation.

Arizona and Nevada are benefiting from population growth, healthcare infrastructure expansion, and increasing laboratory volumes. Automation becomes particularly valuable as hospital systems expand testing capacity while competing for trained laboratory personnel.

Colorado and Utah combine growing health systems with sophisticated academic and molecular testing environments. Utah is particularly relevant to genetics and inherited-disease testing, strengthening its demand for genomic preparation workflows.

Oregon has strong integrated healthcare delivery and academic laboratory capabilities, while New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii represent smaller but strategically relevant markets where centralized laboratory models and automation can help offset distance and workforce limitations.

The Western market is expected to exceed approximately USD 3.0 billion by 2035, with its share increasing as genomic medicine, automated NGS, precision oncology, and high-complexity molecular testing expand.

Northeast

The Northeast is estimated to represent approximately USD 1.20 billion in 2025. The region includes New York, Pennsylvania, Massachusetts, New Jersey, Connecticut, Rhode Island, New Hampshire, Vermont, Maine, and Delaware.

The Northeast has one of the highest concentrations of academic medical centers, pathology programs, cancer institutions, reference laboratories, and biotechnology companies in the country. This creates a premium market for sophisticated sample preparation rather than simply high test volume.

New York is the largest regional state market. New York City and surrounding areas support extensive hospital systems, academic laboratories, oncology centers, genetic testing programs, and major commercial laboratory operations. Sample preparation demand extends from routine pre-analytics to high-throughput molecular extraction and advanced sequencing.

Hospital laboratory consolidation is particularly important in New York because large health systems operate multiple inpatient and outpatient sites. Central molecular laboratories require high-throughput platforms capable of managing specimens arriving continuously from distributed facilities.

Massachusetts has a disproportionately large strategic influence because of Boston’s biotechnology, academic medicine, genomics, and precision oncology ecosystem. Laboratories in the state frequently serve as early evaluators of new sequencing, molecular diagnostic, and sample preparation technologies.

Pennsylvania provides a large hospital and academic testing base through Philadelphia, Pittsburgh, and regional health networks. Oncology, transplantation, inherited disease testing, microbiology, and core laboratory automation support broad demand.

New Jersey combines large healthcare systems with pharmaceutical and biotechnology infrastructure. Connecticut also supports sophisticated academic and health-system laboratories, while Rhode Island, Maine, Vermont, New Hampshire, and Delaware are smaller markets where regional centralization encourages adoption of efficient mid-throughput systems.

The Northeast is expected to approach approximately USD 2.8 billion by 2035. Growth should remain strong even though population expansion is slower than in the South and West because the region generates high-value molecular, oncology, pathology, and genomic testing.

Midwest

The Midwest is estimated at approximately USD 0.96 billion in 2025 and is expected to generate stable expansion throughout the forecast period. The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois represents the largest Midwestern opportunity, supported by Chicago’s extensive hospital, academic, and diagnostic laboratory network. Large integrated systems create demand for automated core laboratory handling, molecular extraction, and consolidated testing infrastructure.

Ohio is strategically important because of its major hospital networks, academic institutions, oncology programs, and high-volume referral centers. Increasing molecular and genomic adoption should drive additional automated preparation investment.

Minnesota has unusual importance because of its medtech and diagnostics ecosystem, strong integrated healthcare organizations, and advanced clinical laboratories. The state frequently supports early adoption of automated workflows and specialized diagnostic technology.

Michigan has a substantial hospital and reference-laboratory base, supporting molecular diagnostics, oncology testing, pathology, and routine laboratory automation.

Wisconsin, Indiana, and Missouri represent stable mid-sized markets with sophisticated regional health systems. Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller by absolute value but provide opportunities for compact automation, regional reference testing, and centralized molecular processing.

Rural laboratory economics are particularly relevant in parts of the Midwest. Smaller hospitals may not justify large robotic platforms, but regional laboratory consolidation can create sufficient volume to support medium-throughput extraction and modular automation. Reliable remote support and simplified operator training are therefore important vendor differentiators.

The Midwest could exceed approximately USD 2.2 billion by 2035, remaining a dependable market for both mature sample preparation technologies and selective adoption of advanced molecular automation.

 

Key Market Players

The U.S. IVD Sample Preparation Systems Competitive Landscape is fragmented across dedicated sample-preparation manufacturers, diversified diagnostics companies, genomics vendors, laboratory automation specialists, and manufacturers of fully integrated sample-to-answer platforms.

Competitive advantage is increasingly determined by installed-base scale, proprietary consumables, extraction chemistry, sample compatibility, automation flexibility, throughput, assay menu, workflow validation, instrument uptime, service infrastructure, data connectivity, and total cost per result.

Some of the key participants relevant to the U.S. IVD sample preparation systems ecosystem include QIAGEN N.V., Thermo Fisher Scientific, Roche Diagnostics, Danaher Corporation, Beckman Coulter Life Sciences, Cepheid, Abbott Laboratories, Hologic, Becton Dickinson, bioMérieux, Hamilton Company, Tecan Group, Revvity, Agilent Technologies, Illumina, Promega Corporation, Siemens Healthineers, Sysmex Corporation, bioMérieux, Bio-Rad Laboratories, Eppendorf, Analytik Jena, PerkinElmer-related Revvity businesses, Takara Bio USA, and Synchron Instrumenten/other specialized automation providers.

QIAGEN has a particularly strong identity in nucleic-acid sample preparation through its extraction kits and automated platforms. The company reported the 4,000th placement of its QIAcube Connect during 2025 and nearly 13,000 cumulative placements across the QIAcube family, demonstrating the scale that dedicated preparation platforms can achieve across clinical and research laboratories.

Thermo Fisher Scientific competes through KingFisher purification platforms, genomic reagents, laboratory equipment, and broad molecular workflows. Beckman Coulter Life Sciences and Hamilton have strong positions in robotic liquid handling and NGS automation. Roche, Hologic, Abbott, Cepheid, BD, Siemens Healthineers, and bioMérieux increasingly integrate sample processing into broader diagnostic platforms, giving them advantages in workflow consolidation.

The competitive landscape is likely to become more ecosystem-oriented through 2035. Laboratory buyers will increasingly prefer vendors that can deliver instruments, consumables, validated workflows, digital connectivity, applications support, preventive service, and integration with downstream analytical platforms.

 

Recent Developments

Recent U.S. industry developments demonstrate that the market is shifting toward higher-throughput automation, flexible molecular workflows, and integrated genomic preparation.

In October 2025, QIAGEN announced the 4,000th placement of QIAcube Connect and highlighted nearly 13,000 cumulative QIAcube-family placements. The company also identified additional automation platforms, including QIAsymphony Connect, QIAsprint, and QIAmini, as part of its broader sample processing roadmap.

In December 2025, Roche announced the U.S. launch of the next-generation cobas 6800/8800 systems and software following FDA 510(k) clearance. The updated platforms were designed to improve throughput, testing flexibility, specimen prioritization, and laboratory resource utilization, highlighting how sample processing is increasingly embedded within high-volume molecular systems.

In October 2025, Hologic received FDA clearance for Panther Fusion gastrointestinal bacterial assays. Expansion of assay menus on fully automated sample-to-result platforms increases instrument utilization and strengthens the economics of consolidated molecular testing.

Automation partnerships have also accelerated. In February 2026, Hamilton and Ultima Genomics announced automated sample preparation and amplification workflows on the Microlab STAR platform for Ultima sequencing systems. In March 2026, Takara Bio USA and Hamilton announced collaboration to automate SMART-Seq library preparation workflows. These developments demonstrate growing demand for prevalidated automation rather than laboratory-by-laboratory development of robotic methods.

The regulatory environment has also changed materially. FDA’s May 2024 rule addressing laboratory-developed tests was vacated by a federal district court on March 31, 2025, and FDA subsequently reverted the relevant regulatory language in September 2025. Laboratories therefore continue to operate within a changing oversight environment, making configurable, well-documented, validated automation strategically valuable even as the regulatory framework evolves.

Separately, Medicare laboratory reimbursement remains an important operating consideration. Current CMS policy provides no applicable phase-in reduction under the relevant CLFS mechanism for 2026, while affected payment reductions beginning in 2027 through 2029 may be limited to 15% annually. This reinforces the financial incentive for laboratories to reduce labor requirements and improve cost per result.

 

Conclusion

The U.S. IVD Sample Preparation Systems Market Size & Share is positioned for substantial expansion from approximately USD 4.92 billion in 2025 to USD 11.84 billion by 2035, representing an estimated 9.18% CAGR during 2026–2035.

The market’s growth is being driven by a structural shift in laboratory economics. U.S. laboratories are processing increasingly complex molecular and genomic tests while facing persistent workforce constraints, reimbursement pressure, quality requirements, and expectations for shorter turnaround times. Sample preparation automation directly addresses these challenges by reducing repetitive labor, standardizing specimen handling, improving reproducibility, lowering contamination risk, and enabling laboratories to increase output without proportionate increases in headcount.

Automated nucleic-acid extraction will remain a major revenue category, but the strongest incremental growth is expected from robotic liquid handling, clinical NGS preparation, liquid biopsy workflows, high-throughput molecular automation, integrated pre-analytics, and sample-to-answer systems.

Oncology and precision medicine will represent particularly important growth engines because the United States diagnoses more than two million new cancer cases annually and increasingly relies on molecular characterization to guide treatment. Infectious disease remains another durable demand base, while hereditary testing, reproductive genetics, transplantation, pharmacogenomics, and specialized molecular diagnostics broaden the long-term addressable market.

Hospitals and health systems will remain the largest buyers, but independent reference laboratories and molecular/genomic diagnostic laboratories will represent some of the most automation-intensive customers. Procurement will increasingly be decided using cost per reportable result, hands-on minutes per specimen, workflow scalability, assay flexibility, staffing impact, instrument utilization, and service reliability.

Regionally, the South will remain the largest market because of its population size, health-system expansion, and growing diagnostic volumes. The West is expected to expand fastest because of its concentration of precision medicine, biotechnology, genomics, and automation adoption. The Northeast will remain a high-value market for academic medicine, molecular pathology, and oncology, while the Midwest will provide a stable base of integrated healthcare systems and regional laboratories.

For companies competing in the market, success will increasingly depend on controlling more of the laboratory workflow rather than selling an isolated instrument. Platforms that combine reliable specimen processing, flexible chemistry, robotic automation, digital connectivity, validated applications, scalable throughput, and recurring consumables will be positioned to capture the greatest economic value.

For healthcare systems, diagnostic laboratories, investors, and manufacturers evaluating this industry, the central strategic question is not whether U.S. laboratories will automate more sample preparation. The more important questions are which workflows will automate first, how rapidly molecular and genomic testing will expand, what level of throughput laboratories will require, and which platforms can deliver measurable improvements in labor productivity, diagnostic quality, and cost per result.

The competitive advantage over the next decade will therefore shift toward vendors capable of converting sample preparation from a manual laboratory step into a standardized, connected, scalable diagnostic production workflow.

 

TABLE OF CONTENT

1. U.S. IVD Sample Preparation Systems Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. IVD Sample Preparation System Manufacturers
1.6.2. Reagent, Consumable, and Extraction Chemistry Suppliers
1.6.3. Laboratory Automation and Liquid Handling Technology Providers
1.6.4. Hospitals and Integrated Health System Laboratories
1.6.5. Independent and Commercial Reference Laboratories
1.6.6. Molecular, Genomic, and Specialty Diagnostic Laboratories
1.6.7. Academic Medical Centers and Translational Laboratories
1.6.8. Group Purchasing Organizations, Distributors, and Laboratory Suppliers
1.6.9. FDA, CMS, CLIA Stakeholders, Payers, and Laboratory Decision-Makers

What this section provides: This section defines the market boundary, research scope, methodology, assumptions, sample preparation workflow, and stakeholder ecosystem so clients understand how the U.S. IVD sample preparation systems market is measured, segmented, and validated.

2. U.S. IVD Sample Preparation Systems Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Opportunity, 2025–2035
2.8. High-Growth Opportunity Areas
2.9. Key Laboratory Automation Adoption Indicators
2.10. Strategic Takeaways for Manufacturers, Laboratories, and Investors

What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast growth, automation adoption, major demand pockets, competitive intensity, and priority investment opportunities.

3. U.S. IVD Sample Preparation Systems Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Expansion of Molecular Diagnostic Testing
3.1.2. Growth of Oncology and Precision Medicine Testing
3.1.3. Rising Adoption of Next-Generation Sequencing in Clinical Laboratories
3.1.4. Increasing Demand for Automated Nucleic Acid Extraction and Purification
3.1.5. Clinical Laboratory Workforce Shortages and Productivity Pressure
3.1.6. Expansion of High-Throughput Reference Laboratory Testing
3.1.7. Growth of Liquid Biopsy and Cell-Free DNA Testing
3.1.8. Demand for Faster Diagnostic Turnaround Times
3.1.9. Hospital and Laboratory Network Consolidation
3.1.10. Increasing Need for Standardized and Reproducible Sample Processing

3.2. Restraints and Their Impact Analysis
3.2.1. High Initial Capital Cost of Advanced Automation Systems
3.2.2. Reagent and Consumable Lock-In Costs
3.2.3. Laboratory Budget Constraints and Reimbursement Pressure
3.2.4. Complex Workflow Validation and Implementation Requirements
3.2.5. Integration Challenges with Existing Laboratory Infrastructure
3.2.6. Limited Economics for Automation in Low-Volume Laboratories

3.3. Opportunities and Their Impact Analysis
3.3.1. Automated NGS Library Preparation
3.3.2. Liquid Biopsy Sample Processing
3.3.3. High-Throughput Molecular Testing Automation
3.3.4. Compact Automation for Community and Regional Laboratories
3.3.5. Open and Flexible Laboratory Automation Platforms
3.3.6. AI-Enabled Workflow Orchestration and Laboratory Analytics
3.3.7. Automated Oncology and Companion Diagnostic Workflows
3.3.8. Decentralized Molecular Diagnostic Laboratories

3.4. Challenges and Their Impact Analysis
3.4.1. Sample Quality and Pre-Analytical Variability
3.4.2. Cross-Contamination and Carryover Risk
3.4.3. Laboratory Information System Integration
3.4.4. Skilled Personnel Requirements for Validation and Troubleshooting
3.4.5. Workflow Standardization Across Multiple Sites
3.4.6. Supply Chain Dependence for Proprietary Consumables

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Laboratory Workflow Economics Analysis
3.7. Laboratory Capital Procurement Behavior Analysis
3.8. Cost-per-Reportable-Result Analysis
3.9. Hands-on-Time and Labor Productivity Analysis
3.10. Laboratory Automation ROI Framework

What this section provides: This section evaluates the clinical, technological, operational, workforce, reimbursement, and economic forces influencing demand for IVD sample preparation systems and helps clients assess both growth potential and execution risk.

4. U.S. IVD Sample Preparation Systems Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Laboratory Buyers
4.2.3. Bargaining Power of Reagent and Component Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry

4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Instrument, Reagent, and Consumable Revenue Model Analysis
4.5. Value Chain & Supply Chain Analysis
4.6. Sample Preparation Workflow Analysis
4.7. Application & Innovation Landscape
4.8. Impact of Laboratory Digitalization and Workflow Connectivity
4.9. Laboratory Information System and Middleware Integration Analysis
4.10. FDA Regulatory Framework Analysis
4.11. CLIA and Clinical Laboratory Compliance Landscape
4.12. CMS Clinical Laboratory Reimbursement Landscape
4.13. Laboratory-Developed Test Regulatory Environment
4.14. Import/Export Restrictions & Tariff Impact
4.15. Government Diagnostic and Public Health Laboratory Initiatives
4.16. Impact of Escalating Geopolitical and Supply Chain Tensions
4.17. Hospital and Laboratory Value Analysis Committee Decision Framework
4.18. Instrument Placement and Reagent-Rental Business Model Analysis

What this section provides: This section provides clients with a complete view of regulation, reimbursement, laboratory economics, pricing, supply chain, workflow digitalization, purchasing models, and external factors influencing sample preparation technology adoption.

5. U.S. IVD Sample Preparation Systems Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Automated Nucleic Acid Extraction & Purification Systems
5.1.2.1. Magnetic Bead-Based Extraction Systems
5.1.2.2. Column-Based Automated Extraction Systems
5.1.2.3. Other Automated Extraction & Purification Systems
5.1.3. Automated Liquid Handling Workstations
5.1.3.1. Benchtop Liquid Handling Systems
5.1.3.2. High-Throughput Robotic Workstations
5.1.3.3. Modular Liquid Handling Platforms
5.1.4. Pre-Analytical Sample Processing Systems
5.1.4.1. Automated Centrifugation Systems
5.1.4.2. Sample Sorting and Routing Systems
5.1.4.3. Decapping and Recapping Systems
5.1.4.4. Automated Aliquoting Systems
5.1.5. NGS & Genomic Sample Preparation Systems
5.1.5.1. Automated DNA/RNA Preparation Systems
5.1.5.2. Automated Library Preparation Systems
5.1.5.3. Target Enrichment and Normalization Systems
5.1.6. Integrated Sample-to-Answer Systems
5.1.6.1. PCR-Based Integrated Systems
5.1.6.2. Multiplex Molecular Diagnostic Platforms
5.1.6.3. Other Integrated Diagnostic Preparation Systems

What this section provides: This section identifies which IVD sample preparation product categories are expected to contribute the greatest revenue and growth, while comparing extraction, liquid handling, pre-analytics, genomic preparation, and integrated sample-to-answer platforms.

6. U.S. IVD Sample Preparation Systems Market – By Sample Type

6.1. Overview
6.1.1. Segment Share Analysis, By Sample Type, 2025 & 2035 (%)
6.1.2. Blood, Plasma & Serum
6.1.2.1. Whole Blood
6.1.2.2. Plasma
6.1.2.3. Serum
6.1.3. Tissue & FFPE Samples
6.1.3.1. Fresh Tissue
6.1.3.2. Frozen Tissue
6.1.3.3. Formalin-Fixed Paraffin-Embedded Tissue
6.1.4. Swabs & Respiratory Specimens
6.1.4.1. Nasal and Nasopharyngeal Swabs
6.1.4.2. Oropharyngeal Swabs
6.1.4.3. Genital and Other Swab Specimens
6.1.5. Urine & Saliva
6.1.5.1. Urine
6.1.5.2. Saliva
6.1.6. Other Body Fluids & Clinical Specimens
6.1.6.1. Cerebrospinal Fluid
6.1.6.2. Stool Specimens
6.1.6.3. Bone Marrow
6.1.6.4. Synovial and Other Specialized Fluids

What this section provides: This section evaluates sample-specific preparation requirements and helps clients identify specimen categories generating the strongest demand for extraction, purification, aliquoting, separation, and automated handling technologies.

7. U.S. IVD Sample Preparation Systems Market – By Application

7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
7.1.2. Molecular & Infectious Disease Diagnostics
7.1.2.1. Respiratory Infectious Disease Testing
7.1.2.2. Sexually Transmitted Infection Testing
7.1.2.3. Gastrointestinal Infectious Disease Testing
7.1.2.4. Blood-Borne and Transplant Infection Testing
7.1.2.5. Emerging Pathogen Testing
7.1.3. Oncology & Precision Medicine
7.1.3.1. Tumor Genomic Profiling
7.1.3.2. Liquid Biopsy
7.1.3.3. Companion Diagnostics
7.1.3.4. Hereditary Cancer Testing
7.1.3.5. Minimal Residual Disease Testing
7.1.4. Genomics & Genetic Testing
7.1.4.1. Hereditary Disease Testing
7.1.4.2. Whole-Exome Sequencing
7.1.4.3. Whole-Genome Sequencing
7.1.4.4. Pharmacogenomics
7.1.4.5. Reproductive & Prenatal Genetics
7.1.5. Clinical Chemistry, Immunodiagnostics & Hematology
7.1.5.1. Clinical Chemistry
7.1.5.2. Immunodiagnostics
7.1.5.3. Hematology
7.1.6. Pathology & Specialized Diagnostics
7.1.6.1. Molecular Pathology
7.1.6.2. Transplant Diagnostics
7.1.6.3. Reproductive Diagnostics
7.1.6.4. Toxicology and Specialty Testing

What this section provides: This section helps clients understand where sample preparation systems are used clinically and identifies molecular diagnostics, oncology, genomics, routine laboratory testing, and specialty diagnostics as distinct commercial opportunity pools.

8. U.S. IVD Sample Preparation Systems Market – By Automation Level

8.1. Overview
8.1.1. Segment Share Analysis, By Automation Level, 2025 & 2035 (%)
8.1.2. Fully Automated Systems
8.1.2.1. High-Throughput Fully Automated Systems
8.1.2.2. Mid-Throughput Fully Automated Systems
8.1.2.3. Compact Fully Automated Systems
8.1.3. Semi-Automated Systems
8.1.3.1. Automated Extraction with Manual Transfer
8.1.3.2. Modular Semi-Automated Workflows
8.1.4. Manual & Modular Sample Preparation Systems
8.1.4.1. Manual Extraction and Purification Platforms
8.1.4.2. Modular Benchtop Preparation Systems

What this section provides: This section evaluates the migration from manual processing toward semi-automated and fully automated workflows and identifies where laboratory labor economics and testing scale are accelerating automation adoption.

9. U.S. IVD Sample Preparation Systems Market – By End User

9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
9.1.2. Hospitals & Integrated Health System Laboratories
9.1.2.1. Academic Medical Center Laboratories
9.1.2.2. Community Hospital Laboratories
9.1.2.3. Centralized Health System Laboratories
9.1.3. Independent & Commercial Reference Laboratories
9.1.3.1. National Reference Laboratories
9.1.3.2. Regional Reference Laboratories
9.1.4. Molecular & Genomic Diagnostic Laboratories
9.1.4.1. Molecular Diagnostic Laboratories
9.1.4.2. Clinical Genomics Laboratories
9.1.4.3. Precision Oncology Laboratories
9.1.5. Academic Medical Centers & Research-Integrated Clinical Laboratories
9.1.6. Specialty Laboratories & Other Diagnostic Facilities
9.1.6.1. Oncology Laboratories
9.1.6.2. Pathology Laboratories
9.1.6.3. Fertility and Reproductive Laboratories
9.1.6.4. Public Health Laboratories
9.1.6.5. Transplant and Specialty Diagnostic Laboratories

What this section provides: This section identifies the principal laboratory customer groups purchasing IVD sample preparation systems and evaluates differences in throughput requirements, capital budgets, workflow complexity, and automation priorities.

10. U.S. IVD Sample Preparation Systems Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Clinical Laboratory Infrastructure Analysis
10.1.4. Regional Molecular and Genomic Testing Intensity Analysis
10.1.5. Regional Laboratory Automation Adoption Analysis
10.1.6. Regional Procurement and Reimbursement Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers and Laboratory Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers and Laboratory Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers and Laboratory Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers and Laboratory Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Automation Level, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level market intelligence across all 50 U.S. states, helping clients identify laboratory automation hubs, molecular and genomic testing hotspots, high-value hospital and reference laboratory clusters, regional adoption differences, and priority commercial opportunities.

11. U.S. IVD Sample Preparation Systems Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking Analysis
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Product Portfolio Benchmarking
11.5. Automation Capability Benchmarking
11.6. Installed Base and Laboratory Workflow Positioning
11.7. Strategic Partnerships, Collaborations & Distribution Analysis
11.8. Mergers, Acquisitions & Portfolio Expansion Analysis
11.9. Company Profiles

11.9.1. QIAGEN N.V.
11.9.2. Thermo Fisher Scientific Inc.
11.9.3. F. Hoffmann-La Roche Ltd. / Roche Diagnostics
11.9.4. Beckman Coulter Life Sciences
11.9.5. Hamilton Company
11.9.6. Tecan Group Ltd.
11.9.7. Revvity, Inc.
11.9.8. Agilent Technologies, Inc.
11.9.9. Illumina, Inc.
11.9.10. Promega Corporation
11.9.11. Hologic, Inc.
11.9.12. Abbott Laboratories
11.9.13. Becton, Dickinson and Company
11.9.14. Cepheid
11.9.15. bioMérieux SA
11.9.16. Bio-Rad Laboratories, Inc.
11.9.17. Eppendorf SE
11.9.18. Analytik Jena GmbH+Co. KG
11.9.19. Takara Bio USA, Inc.
11.9.20. Siemens Healthineers
11.9.21. Sysmex Corporation
11.9.22. INTEGRA Biosciences AG
11.9.23. SPT Labtech
11.9.24. Opentrons Labworks Inc.
11.9.25. DiaSorin S.p.A.

Note: Each company profile will include company overview, U.S. sample preparation portfolio, automated extraction and liquid handling capabilities, major applications, U.S. laboratory market strategy, installed-base positioning, partnerships, regulatory developments, innovation pipeline, and recent strategic developments.

What this section provides: This section provides competitor benchmarking, market-share visibility, product and automation positioning, installed-base intelligence, workflow differentiation, and strategic analysis of major participants competing in the U.S. IVD sample preparation systems market.

12. U.S. IVD Sample Preparation Systems Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario

12.2. Disruptive Technologies Impact
12.2.1. Fully Automated Nucleic Acid Extraction
12.2.2. Automated NGS Library Preparation
12.2.3. Robotic Liquid Handling and Laboratory Orchestration
12.2.4. Sample-to-Answer Molecular Diagnostic Platforms
12.2.5. AI-Assisted Laboratory Workflow Optimization
12.2.6. Liquid Biopsy and Cell-Free DNA Preparation Technologies
12.2.7. Microfluidic Sample Preparation
12.2.8. Digital Laboratory Connectivity and Intelligent Automation

12.3. Emerging Business Trends
12.3.1. Reagent-Rental and Instrument Placement Models
12.3.2. Laboratory Automation-as-a-Service
12.3.3. Open Automation Architecture
12.3.4. Multi-Assay Workflow Consolidation
12.3.5. Centralization of Molecular and Genomic Testing

12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Technology Adoption Roadmap, 2026–2035
12.7. Laboratory Workflow Transformation Outlook
12.8. Market White-Space Opportunity Analysis

What this section provides: This section prepares clients for future changes in laboratory workflow, automation architecture, molecular diagnostics, NGS preparation, business models, disruptive technologies, and investment opportunities through 2035.

13. U.S. IVD Sample Preparation Systems Market: Strategic Recommendations

13.1. Recommendations for IVD Sample Preparation System Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Independent and Commercial Laboratories
13.4. Recommendations for Molecular and Genomic Diagnostic Laboratories
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. U.S. Go-to-Market Strategy Considerations
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. Instrument Placement and Consumable Revenue Strategy
13.11. Laboratory Workflow Partnership Strategy
13.12. High-Growth Application Prioritization
13.13. State and Regional Commercial Expansion Priorities

What this section provides: This section converts market intelligence into actionable recommendations for product development, laboratory penetration, portfolio positioning, recurring consumable revenue, geographic expansion, channel strategy, investment planning, and competitive differentiation.

14. U.S. IVD Sample Preparation Systems Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Sizing and Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Regulatory and Reimbursement Information Disclaimer

What this section provides: This section clarifies the report’s scope limitations, data-use conditions, forecasting assumptions, regulatory information boundaries, legal considerations, and limitations associated with third-party market intelligence.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. IVD Sample Preparation Systems Market: Market Definition and Scope
TABLE 3: U.S. IVD Sample Preparation Systems Market: Research Methodology Framework
TABLE 4: U.S. IVD Sample Preparation Systems Market: Key Assumptions
TABLE 5: U.S. IVD Sample Preparation Systems Market: Market Ecosystem Overview
TABLE 6: U.S. IVD Sample Preparation Systems Market: Stakeholder Analysis
TABLE 7: U.S. IVD Sample Preparation Systems Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. IVD Sample Preparation Systems Market: Analyst Viewpoint Summary
TABLE 9: U.S. IVD Sample Preparation Systems Market: Market Attractiveness Index
TABLE 10: U.S. IVD Sample Preparation Systems Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. IVD Sample Preparation Systems Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. IVD Sample Preparation Systems Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. IVD Sample Preparation Systems Market: High-Growth Opportunity Areas
TABLE 14: U.S. IVD Sample Preparation Systems Market: Drivers; Impact Analysis
TABLE 15: U.S. IVD Sample Preparation Systems Market: Restraints; Impact Analysis
TABLE 16: U.S. IVD Sample Preparation Systems Market: Opportunities; Impact Analysis
TABLE 17: U.S. IVD Sample Preparation Systems Market: Challenges; Impact Analysis
TABLE 18: U.S. IVD Sample Preparation Systems Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. IVD Sample Preparation Systems Market: Clinical Laboratory Workflow Economics Matrix
TABLE 20: U.S. IVD Sample Preparation Systems Market: Laboratory Capital Procurement Behavior Matrix
TABLE 21: U.S. IVD Sample Preparation Systems Market: Cost-per-Reportable-Result Analysis
TABLE 22: U.S. IVD Sample Preparation Systems Market: Hands-on-Time and Labor Productivity Analysis
TABLE 23: U.S. IVD Sample Preparation Systems Market: Laboratory Automation ROI Framework
TABLE 24: U.S. IVD Sample Preparation Systems Market: PESTEL Analysis
TABLE 25: U.S. IVD Sample Preparation Systems Market: Porter’s Five Forces Analysis
TABLE 26: U.S. IVD Sample Preparation Systems Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 27: U.S. IVD Sample Preparation Systems Market: Instrument, Reagent and Consumable Revenue Model Analysis
TABLE 28: U.S. IVD Sample Preparation Systems Market: Value Chain Analysis
TABLE 29: U.S. IVD Sample Preparation Systems Market: Supply Chain Analysis
TABLE 30: U.S. IVD Sample Preparation Systems Market: Sample Preparation Workflow Analysis
TABLE 31: U.S. IVD Sample Preparation Systems Market: Application & Innovation Landscape
TABLE 32: U.S. IVD Sample Preparation Systems Market: Laboratory Digitalization and Workflow Connectivity Impact
TABLE 33: U.S. IVD Sample Preparation Systems Market: LIS and Middleware Integration Analysis
TABLE 34: U.S. IVD Sample Preparation Systems Market: FDA Regulatory Framework Analysis
TABLE 35: U.S. IVD Sample Preparation Systems Market: CLIA and Clinical Laboratory Compliance Landscape
TABLE 36: U.S. IVD Sample Preparation Systems Market: CMS Clinical Laboratory Reimbursement Landscape
TABLE 37: U.S. IVD Sample Preparation Systems Market: Laboratory-Developed Test Regulatory Environment
TABLE 38: U.S. IVD Sample Preparation Systems Market: Import/Export Restrictions & Tariff Impact
TABLE 39: U.S. IVD Sample Preparation Systems Market: Government Diagnostic and Public Health Laboratory Initiatives
TABLE 40: U.S. IVD Sample Preparation Systems Market: Impact of Escalating Geopolitical and Supply Chain Tensions
TABLE 41: U.S. IVD Sample Preparation Systems Market: Laboratory Value Analysis Committee Decision Framework
TABLE 42: U.S. IVD Sample Preparation Systems Market: Instrument Placement and Reagent-Rental Business Model Analysis
TABLE 43: U.S. IVD Sample Preparation Systems Market: Product Type Snapshot, 2025
TABLE 44: Segment Dashboard; Definition and Scope, by Product Type
TABLE 45: U.S. IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 46: U.S. IVD Sample Preparation Systems Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 47: U.S. IVD Sample Preparation Systems Market: Automated Nucleic Acid Extraction & Purification Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. IVD Sample Preparation Systems Market: Automated Liquid Handling Workstations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. IVD Sample Preparation Systems Market: Pre-Analytical Sample Processing Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. IVD Sample Preparation Systems Market: NGS & Genomic Sample Preparation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. IVD Sample Preparation Systems Market: Integrated Sample-to-Answer Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. IVD Sample Preparation Systems Market: Sample Type Snapshot, 2025
TABLE 53: Segment Dashboard; Definition and Scope, by Sample Type
TABLE 54: U.S. IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 55: U.S. IVD Sample Preparation Systems Market: Segment Share Analysis, by Sample Type, 2025 & 2035 (%)
TABLE 56: U.S. IVD Sample Preparation Systems Market: Blood, Plasma & Serum Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. IVD Sample Preparation Systems Market: Tissue & FFPE Samples Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. IVD Sample Preparation Systems Market: Swabs & Respiratory Specimens Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. IVD Sample Preparation Systems Market: Urine & Saliva Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. IVD Sample Preparation Systems Market: Other Body Fluids & Clinical Specimens Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. IVD Sample Preparation Systems Market: Application Snapshot, 2025
TABLE 62: Segment Dashboard; Definition and Scope, by Application
TABLE 63: U.S. IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 64: U.S. IVD Sample Preparation Systems Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 65: U.S. IVD Sample Preparation Systems Market: Molecular & Infectious Disease Diagnostics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. IVD Sample Preparation Systems Market: Oncology & Precision Medicine Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. IVD Sample Preparation Systems Market: Genomics & Genetic Testing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. IVD Sample Preparation Systems Market: Clinical Chemistry, Immunodiagnostics & Hematology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. IVD Sample Preparation Systems Market: Pathology & Specialized Diagnostics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. IVD Sample Preparation Systems Market: Automation Level Snapshot, 2025
TABLE 71: Segment Dashboard; Definition and Scope, by Automation Level
TABLE 72: U.S. IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 73: U.S. IVD Sample Preparation Systems Market: Segment Share Analysis, by Automation Level, 2025 & 2035 (%)
TABLE 74: U.S. IVD Sample Preparation Systems Market: Fully Automated Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. IVD Sample Preparation Systems Market: Semi-Automated Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. IVD Sample Preparation Systems Market: Manual & Modular Sample Preparation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. IVD Sample Preparation Systems Market: End User Snapshot, 2025
TABLE 78: Segment Dashboard; Definition and Scope, by End User
TABLE 79: U.S. IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 80: U.S. IVD Sample Preparation Systems Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 81: U.S. IVD Sample Preparation Systems Market: Hospitals & Integrated Health System Laboratories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. IVD Sample Preparation Systems Market: Independent & Commercial Reference Laboratories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. IVD Sample Preparation Systems Market: Molecular & Genomic Diagnostic Laboratories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. IVD Sample Preparation Systems Market: Academic Medical Centers & Research-Integrated Clinical Laboratories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. IVD Sample Preparation Systems Market: Specialty Laboratories & Other Diagnostic Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. IVD Sample Preparation Systems Market: Regional Snapshot, 2025
TABLE 87: Segment Dashboard; Definition and Scope, by Region
TABLE 88: U.S. IVD Sample Preparation Systems Market, by Region, 2021–2035 (US$ Billion)
TABLE 89: U.S. IVD Sample Preparation Systems Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 90: West Region U.S. IVD Sample Preparation Systems Market: Regional Overview and Trends
TABLE 91: West Region U.S. IVD Sample Preparation Systems Market: Key Manufacturers and Laboratory Procurement Ecosystem
TABLE 92: West Region U.S. IVD Sample Preparation Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 98: California IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 99: California IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 100: California IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 101: California IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 102: California IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 103: Washington IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 104: Washington IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 105: Washington IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 106: Washington IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 107: Washington IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 108: Arizona IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 109: Arizona IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 110: Arizona IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 111: Arizona IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 112: Arizona IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 113: Colorado IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 114: Colorado IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 115: Colorado IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 116: Colorado IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 117: Colorado IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 118: Oregon IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 119: Oregon IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 120: Oregon IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 121: Oregon IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 122: Oregon IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 123: Utah IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 124: Utah IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 125: Utah IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 126: Utah IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 127: Utah IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 128: Nevada IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 129: Nevada IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 130: Nevada IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 131: Nevada IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 132: Nevada IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 133: New Mexico IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 134: New Mexico IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 135: New Mexico IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 136: New Mexico IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 137: New Mexico IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 138: Idaho IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 139: Idaho IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 140: Idaho IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 141: Idaho IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 142: Idaho IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 143: Montana IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 144: Montana IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 145: Montana IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 146: Montana IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 147: Montana IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 148: Wyoming IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 149: Wyoming IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 150: Wyoming IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 151: Wyoming IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 152: Wyoming IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 153: Alaska IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 154: Alaska IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 155: Alaska IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 156: Alaska IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 157: Alaska IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 158: Hawaii IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 159: Hawaii IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 160: Hawaii IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 161: Hawaii IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 162: Hawaii IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 163: Northeast Region U.S. IVD Sample Preparation Systems Market: Regional Overview and Trends
TABLE 164: Northeast Region U.S. IVD Sample Preparation Systems Market: Key Manufacturers and Laboratory Procurement Ecosystem
TABLE 165: Northeast Region U.S. IVD Sample Preparation Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 166: Northeast Region U.S. IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 169: Northeast Region U.S. IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 171: New York IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 172: New York IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 173: New York IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 174: New York IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 175: New York IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 176: Massachusetts IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 179: Massachusetts IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 181: New Jersey IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 182: New Jersey IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 183: New Jersey IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 184: New Jersey IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 185: New Jersey IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 186: Pennsylvania IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 189: Pennsylvania IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 191: Connecticut IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 192: Connecticut IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 193: Connecticut IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 194: Connecticut IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 195: Connecticut IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 196: Maine IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 197: Maine IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 198: Maine IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 199: Maine IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 200: Maine IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 201: Vermont IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 202: Vermont IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 203: Vermont IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 204: Vermont IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 205: Vermont IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 206: New Hampshire IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 209: New Hampshire IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 211: Rhode Island IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 214: Rhode Island IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 216: Delaware IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 217: Delaware IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 218: Delaware IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 219: Delaware IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 220: Delaware IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 221: South Region U.S. IVD Sample Preparation Systems Market: Regional Overview and Trends
TABLE 222: South Region U.S. IVD Sample Preparation Systems Market: Key Manufacturers and Laboratory Procurement Ecosystem
TABLE 223: South Region U.S. IVD Sample Preparation Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 224: South Region U.S. IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 229: Texas IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 230: Texas IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 231: Texas IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 232: Texas IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 233: Texas IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 234: Florida IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 235: Florida IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 236: Florida IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 237: Florida IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 238: Florida IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 239: Georgia IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 240: Georgia IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 241: Georgia IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 242: Georgia IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 243: Georgia IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 244: North Carolina IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 245: North Carolina IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 246: North Carolina IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 247: North Carolina IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 248: North Carolina IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 249: Tennessee IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 250: Tennessee IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 251: Tennessee IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 252: Tennessee IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 253: Tennessee IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 254: South Carolina IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 255: South Carolina IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 256: South Carolina IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 257: South Carolina IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 258: South Carolina IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 259: Alabama IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 260: Alabama IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 261: Alabama IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 262: Alabama IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 263: Alabama IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 264: Mississippi IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 265: Mississippi IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 266: Mississippi IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 267: Mississippi IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 268: Mississippi IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 269: Louisiana IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 270: Louisiana IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 271: Louisiana IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 272: Louisiana IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 273: Louisiana IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 274: Arkansas IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 275: Arkansas IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 276: Arkansas IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 277: Arkansas IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 278: Arkansas IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 279: Kentucky IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 280: Kentucky IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 281: Kentucky IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 282: Kentucky IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 283: Kentucky IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 284: Oklahoma IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 288: Oklahoma IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 289: Virginia IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 290: Virginia IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 291: Virginia IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 292: Virginia IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 293: Virginia IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 294: Maryland IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 295: Maryland IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 296: Maryland IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 297: Maryland IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 298: Maryland IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 299: West Virginia IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 300: West Virginia IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 301: West Virginia IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 302: West Virginia IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 303: West Virginia IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 304: Midwest Region U.S. IVD Sample Preparation Systems Market: Regional Overview and Trends
TABLE 305: Midwest Region U.S. IVD Sample Preparation Systems Market: Key Manufacturers and Laboratory Procurement Ecosystem
TABLE 306: Midwest Region U.S. IVD Sample Preparation Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 307: Midwest Region U.S. IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 310: Midwest Region U.S. IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 311: Midwest Region U.S. IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 312: Illinois IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 313: Illinois IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 314: Illinois IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 315: Illinois IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 316: Illinois IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 317: Ohio IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 318: Ohio IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 319: Ohio IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 320: Ohio IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 321: Ohio IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 322: Michigan IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 323: Michigan IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 324: Michigan IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 325: Michigan IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 326: Michigan IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 327: Minnesota IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 328: Minnesota IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 329: Minnesota IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 330: Minnesota IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 331: Minnesota IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 332: Indiana IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 333: Indiana IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 334: Indiana IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 335: Indiana IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 336: Indiana IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 337: Wisconsin IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 339: Wisconsin IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 340: Wisconsin IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 341: Wisconsin IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 342: Missouri IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 343: Missouri IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 344: Missouri IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 345: Missouri IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 346: Missouri IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 347: Iowa IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 348: Iowa IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 349: Iowa IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 350: Iowa IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 351: Iowa IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 352: Kansas IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 353: Kansas IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 354: Kansas IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 355: Kansas IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 356: Kansas IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 357: Nebraska IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 358: Nebraska IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 359: Nebraska IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 360: Nebraska IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 361: Nebraska IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 362: North Dakota IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 363: North Dakota IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 364: North Dakota IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 365: North Dakota IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 366: North Dakota IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 367: South Dakota IVD Sample Preparation Systems Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 368: South Dakota IVD Sample Preparation Systems Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 369: South Dakota IVD Sample Preparation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 370: South Dakota IVD Sample Preparation Systems Market, by Automation Level, 2021–2035 (US$ Billion)
TABLE 371: South Dakota IVD Sample Preparation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 372: U.S. IVD Sample Preparation Systems Market: Competitive Landscape Snapshot, 2025
TABLE 373: U.S. IVD Sample Preparation Systems Market: Key Company Market Share Analysis, 2025
TABLE 374: U.S. IVD Sample Preparation Systems Market: Company Positioning Matrix
TABLE 375: U.S. IVD Sample Preparation Systems Market: Product Portfolio Benchmarking of Key Players
TABLE 376: U.S. IVD Sample Preparation Systems Market: Automation Capability Benchmarking
TABLE 377: U.S. IVD Sample Preparation Systems Market: Installed Base and Laboratory Workflow Positioning
TABLE 378: U.S. IVD Sample Preparation Systems Market: Strategic Partnerships, Collaborations & Distribution Analysis
TABLE 379: U.S. IVD Sample Preparation Systems Market: Mergers, Acquisitions & Portfolio Expansion Analysis
TABLE 380: QIAGEN N.V.: Company Profile
TABLE 381: Thermo Fisher Scientific Inc.: Company Profile
TABLE 382: F. Hoffmann-La Roche Ltd. / Roche Diagnostics: Company Profile
TABLE 383: Beckman Coulter Life Sciences: Company Profile
TABLE 384: Hamilton Company: Company Profile
TABLE 385: Tecan Group Ltd.: Company Profile
TABLE 386: Revvity, Inc.: Company Profile
TABLE 387: Agilent Technologies, Inc.: Company Profile
TABLE 388: Illumina, Inc.: Company Profile
TABLE 389: Promega Corporation: Company Profile
TABLE 390: Hologic, Inc.: Company Profile
TABLE 391: Abbott Laboratories: Company Profile
TABLE 392: Becton, Dickinson and Company: Company Profile
TABLE 393: Cepheid: Company Profile
TABLE 394: bioMérieux SA: Company Profile
TABLE 395: Bio-Rad Laboratories, Inc.: Company Profile
TABLE 396: Eppendorf SE: Company Profile
TABLE 397: Analytik Jena GmbH+Co. KG: Company Profile
TABLE 398: Takara Bio USA, Inc.: Company Profile
TABLE 399: Siemens Healthineers: Company Profile
TABLE 400: Sysmex Corporation: Company Profile
TABLE 401: INTEGRA Biosciences AG: Company Profile
TABLE 402: SPT Labtech: Company Profile
TABLE 403: Opentrons Labworks Inc.: Company Profile
TABLE 404: DiaSorin S.p.A.: Company Profile
TABLE 405: U.S. IVD Sample Preparation Systems Market: Future Market Scenario Analysis, 2026–2035
TABLE 406: U.S. IVD Sample Preparation Systems Market: Disruptive Technologies Impact Matrix
TABLE 407: U.S. IVD Sample Preparation Systems Market: Emerging Business Trends
TABLE 408: U.S. IVD Sample Preparation Systems Market: Business Opportunities for Startups and Existing Players
TABLE 409: U.S. IVD Sample Preparation Systems Market: Investment Prioritization Matrix
TABLE 410: U.S. IVD Sample Preparation Systems Market: Technology Adoption Roadmap, 2026–2035
TABLE 411: U.S. IVD Sample Preparation Systems Market: Laboratory Workflow Transformation Outlook
TABLE 412: U.S. IVD Sample Preparation Systems Market: Market White-Space Opportunity Analysis
TABLE 413: U.S. IVD Sample Preparation Systems Market: Strategic Recommendations for IVD Sample Preparation System Manufacturers
TABLE 414: U.S. IVD Sample Preparation Systems Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 415: U.S. IVD Sample Preparation Systems Market: Strategic Recommendations for Independent and Commercial Laboratories
TABLE 416: U.S. IVD Sample Preparation Systems Market: Strategic Recommendations for Molecular and Genomic Diagnostic Laboratories
TABLE 417: U.S. IVD Sample Preparation Systems Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 418: U.S. IVD Sample Preparation Systems Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 419: U.S. IVD Sample Preparation Systems Market: Strategic Recommendations for New Entrants and Startups
TABLE 420: U.S. IVD Sample Preparation Systems Market: U.S. Go-to-Market Strategy Considerations
TABLE 421: U.S. IVD Sample Preparation Systems Market: Product Positioning and Portfolio Expansion Guidance
TABLE 422: U.S. IVD Sample Preparation Systems Market: Instrument Placement and Consumable Revenue Strategy
TABLE 423: U.S. IVD Sample Preparation Systems Market: Laboratory Workflow Partnership Strategy
TABLE 424: U.S. IVD Sample Preparation Systems Market: High-Growth Application Prioritization
TABLE 425: U.S. IVD Sample Preparation Systems Market: State and Regional Commercial Expansion Priorities
TABLE 426: U.S. IVD Sample Preparation Systems Market: Scope Limitation
TABLE 427: U.S. IVD Sample Preparation Systems Market: Data Use Limitation
TABLE 428: U.S. IVD Sample Preparation Systems Market: Market Sizing and Forecasting Limitation
TABLE 429: U.S. IVD Sample Preparation Systems Market: Legal Disclaimer
TABLE 430: U.S. IVD Sample Preparation Systems Market: Third-Party Data Disclaimer
TABLE 431: U.S. IVD Sample Preparation Systems Market: Regulatory and Reimbursement Information Disclaimer

List of Figures

FIGURE 1: U.S. IVD Sample Preparation Systems Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Framework
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Laboratory Workflow Economics Framework
FIGURE 12: Laboratory Capital Procurement Decision Framework
FIGURE 13: Cost-per-Reportable-Result Framework
FIGURE 14: Laboratory Automation ROI Framework
FIGURE 15: U.S. IVD Sample Preparation Systems Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 16: U.S. IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 17: U.S. IVD Sample Preparation Systems Market Year-wise Growth Curve, 2021–2035
FIGURE 18: Laboratory Digitalization and Workflow Connectivity Framework
FIGURE 19: FDA, CLIA and CMS Regulatory-Reimbursement Landscape
FIGURE 20: Instrument Placement and Reagent-Rental Business Model Framework
FIGURE 21: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 22: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Automated Nucleic Acid Extraction & Purification Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Automated Liquid Handling Workstations Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Pre-Analytical Sample Processing Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: NGS & Genomic Sample Preparation Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Integrated Sample-to-Answer Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Sample Type Segment Market Share Analysis, 2025 & 2035
FIGURE 29: Sample Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Blood, Plasma & Serum Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Tissue & FFPE Samples Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Swabs & Respiratory Specimens Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Urine & Saliva Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Other Body Fluids & Clinical Specimens Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 36: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Molecular & Infectious Disease Diagnostics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Oncology & Precision Medicine Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Genomics & Genetic Testing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Clinical Chemistry, Immunodiagnostics & Hematology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Pathology & Specialized Diagnostics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Automation Level Segment Market Share Analysis, 2025 & 2035
FIGURE 43: Automation Level Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Fully Automated Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Semi-Automated Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Manual & Modular Sample Preparation Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 48: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Hospitals & Integrated Health System Laboratories Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Independent & Commercial Reference Laboratories Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Molecular & Genomic Diagnostic Laboratories Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Academic Medical Centers & Research-Integrated Clinical Laboratories Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Specialty Laboratories & Other Diagnostic Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: West Region U.S. IVD Sample Preparation Systems Market Share and Leading Players, 2025
FIGURE 57: West Region Market Share Analysis by State, 2025
FIGURE 58: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: California IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Washington IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Arizona IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Colorado IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Oregon IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Utah IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Nevada IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: New Mexico IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Idaho IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Montana IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Wyoming IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Alaska IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Hawaii IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Northeast Region U.S. IVD Sample Preparation Systems Market Share and Leading Players, 2025
FIGURE 73: Northeast Region Market Share Analysis by State, 2025
FIGURE 74: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New York IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Massachusetts IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New Jersey IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Pennsylvania IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Connecticut IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Maine IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Vermont IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: New Hampshire IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Rhode Island IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Delaware IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: South Region U.S. IVD Sample Preparation Systems Market Share and Leading Players, 2025
FIGURE 86: South Region Market Share Analysis by State, 2025
FIGURE 87: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Texas IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Florida IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Georgia IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: North Carolina IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Tennessee IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: South Carolina IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Alabama IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Mississippi IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Louisiana IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Arkansas IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Kentucky IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Oklahoma IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Virginia IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Maryland IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: West Virginia IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Midwest Region U.S. IVD Sample Preparation Systems Market Share and Leading Players, 2025
FIGURE 104: Midwest Region Market Share Analysis by State, 2025
FIGURE 105: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Illinois IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Ohio IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Michigan IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Minnesota IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Indiana IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Wisconsin IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Missouri IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Iowa IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Kansas IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Nebraska IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: North Dakota IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: South Dakota IVD Sample Preparation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 119: Company Positioning Matrix
FIGURE 120: Key Player Product Portfolio Benchmarking
FIGURE 121: Automation Capability Benchmarking
FIGURE 122: Installed Base and Laboratory Workflow Positioning
FIGURE 123: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 124: IVD Sample Preparation Innovation Roadmap
FIGURE 125: Automated Nucleic Acid Extraction Adoption Roadmap
FIGURE 126: Automated NGS Library Preparation Opportunity Map
FIGURE 127: Robotic Liquid Handling and Laboratory Orchestration Roadmap
FIGURE 128: Sample-to-Answer Molecular Diagnostics Growth Roadmap
FIGURE 129: Future Market Scenario Analysis, 2026–2035
FIGURE 130: Disruptive Technologies Impact Matrix
FIGURE 131: Emerging Business Trends Matrix
FIGURE 132: Investment Prioritization Matrix
FIGURE 133: Technology Adoption Roadmap, 2026–2035
FIGURE 134: Laboratory Workflow Transformation Roadmap
FIGURE 135: Market White-Space Opportunity Map
FIGURE 136: Strategic Growth Roadmap for U.S. IVD Sample Preparation System Companies
FIGURE 137: U.S. Go-to-Market Strategy Framework
FIGURE 138: Product Positioning and Portfolio Expansion Framework
FIGURE 139: Instrument Placement and Consumable Revenue Strategy Framework
FIGURE 140: State and Regional Commercial Expansion Priority Map
FIGURE 141: Report Scope and Disclaimer Framework